Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis.

Breast (Edinburgh, Scotland) - 1 Feb 2020

Ben-David Merav A, Corn Benjamin W, Evron Ella, Goldberg Hadassah, Pfeffer Raphael M, Abdah-Bortnyak Roxoliana, Matceyevsky Dianna, Weinstein Yuliana, Golan Orit, Sklair-Levy Miri

Abstract excerpt

PURPOSE: We recently showed that prophylactic breast irradiation (PBI) reduces the risk of contralateral breast cancer in BRCA mutation carriers undergoing treatment for early breast cancer. It has been suggested that Background Parenchymal Enhancement (BPE) may be a biomarker for increased risk of breast cancer. METHODS: For participants in the trial we reviewed the MRI prior to enrollment and following...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast

Share to Breast Neoplasms

Share to Image Enhancement

Share to Magnetic Resonance Imaging

Share to Radiotherapy

Source

Open in PubMed Open full text

Identifiers

PMID: 31734591
DOI: 10.1016/j.breast.2019.10.011
PMCID: PMC7375590

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis.PMID 31734591Read ↗

Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.Semantic proximity Read ↗

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.Semantic proximity Read ↗

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women.Semantic proximity Read ↗

Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.Semantic proximity Read ↗

Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.Semantic proximity Read ↗

Assessment of Background Parenchymal Enhancement and Lesion Kinetics in Breast MRI of BRCA 1/2 Mutation Carriers Compared to Matched Controls Using Quantitative Kinetic Analysis.Semantic proximity Read ↗

Qualitative Assessments of Density and Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography Associated with Breast Cancer Risk of High-Risk WomenSemantic proximity Read ↗

The role of dynamic contrast-enhanced screening breast MRI in populations at increased risk for breast cancer.Semantic proximity Read ↗

Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

MRI screening for breast cancer in high-risk patients.Semantic proximity Read ↗

Update on screening breast MRI in high-risk women.Semantic proximity Read ↗

Update on screening breast MRI in high-risk women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.